Disc Medicine Stock (NASDAQ:IRON)
Previous Close
$59.03
52W Range
$30.82 - $68.73
50D Avg
$55.53
200D Avg
$54.56
Market Cap
$2.12B
Avg Vol (3M)
$372.29K
Beta
2.50
Div Yield
-
IRON Company Profile
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.